Statistical modeling for quality risk assessment of clinical trials: follow-up at the era of remote auditing
View ORCID ProfileBjörn Koneswarakantha, View ORCID ProfileTimothé Ménard
doi: https://doi.org/10.1101/2021.07.12.21260214
Björn Koneswarakantha
1F. Hoffmann-La Roche AG - CH-4070, Basel, Switzerland
PhDTimothé Ménard
1F. Hoffmann-La Roche AG - CH-4070, Basel, Switzerland
PharmDArticle usage
Posted February 05, 2022.
Statistical modeling for quality risk assessment of clinical trials: follow-up at the era of remote auditing
Björn Koneswarakantha, Timothé Ménard
medRxiv 2021.07.12.21260214; doi: https://doi.org/10.1101/2021.07.12.21260214
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11625)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3391)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (410)
- Public and Global Health (6022)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)